Skip to main content

Organizing pneumonia causing severe respiratory failure as a complication of interferon-α therapy

Abstract

Chronic hepatitis C infection is highly prevalent in Egypt. Pegylated interferon-α (in addition to ribavirin) is the standard medication and it is increasingly being used. Despite being very uncommon, interferon therapy has been associated with a plethora of pleuropulmonary complications ranging from mild asthma exacerbation to acute respiratory distress syndrome (ARDS) and death. This is a report of a case of organizing pneumonia occurring in the course of interferon therapy that has been complicated with severe respiratory failure. The pulmonary lesions have miraculously resolved after 10 days of corticosteroid therapy.

References

  1. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355:887–891.

    Article  CAS  Google Scholar 

  2. Slavenburg S, Heijdra YF, Drenth JP. Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature. Dig Dis Sci 2010; 55:579–585.

    Article  CAS  Google Scholar 

  3. Atug O, Akin H, Alahdab YO, Ceyhan B, Tozun N, Ozdogan O. Interstitial pneumonitis associated with pegylated interferon-alpha 2a and ribavirin for chronic hepatitis C infection: a case report. Cases J 2009; 2:6464.

    Article  Google Scholar 

  4. Midturi J, Sierra-Hoffman M, Hurley D, Winn R, Beissner R, Carpenter J. Spectrum of pulmonary toxicity associated with the use of interferon therapy for hepatitis C: case report and review of the literature. Clin Infect Dis 2004;39:1724–1729.

    Article  Google Scholar 

  5. Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 1987; 59:896–900.

    Article  CAS  Google Scholar 

  6. Kamisako T, Adachi Y, Chihara J, Yamamoto T. Interstitial pneumonitis and interferon-alfa. BMJ 1993; 306:896.

    Article  CAS  Google Scholar 

  7. Camus P. Interferon alpha/beta induced lung disease [Internet]. Pneumotox. Available at: http://www.pneumotox.com/drug/view/161/ interferon-alpha-beta/ [Last accessed on 2015 May 14].

  8. Borden EC, Parkinson D. A perspective on the clinical effectiveness and tolerance of interferon-alpha. Semin Oncol 1998; 25 (Suppl 1): 3–8.

    PubMed  CAS  Google Scholar 

  9. Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN. Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med 2008; 3:67–75.

    Article  Google Scholar 

  10. Kim SJ, Lee KS, Ryu YH, Yoon YC, Choe KO, Kim TS, Sung KJ. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am J Roentgenol 2003; 180: 1251–1254.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maged Hassan MSc.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassan, M., Essam, H. Organizing pneumonia causing severe respiratory failure as a complication of interferon-α therapy. Egypt J Bronchol 10, 73–75 (2016). https://doi.org/10.4103/1687-8426.176799

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.176799

Keywords